Evonile Pharma Limited Passes Special Resolutions for Employee Stock Options and Asset Charge Creation with Over 99% Shareholder Approval
Shareholders approved granting at least 1% of issued share capital in stock options and sanctioned creation of charge on company assets as of November 12, 2026
Evonile Pharma Limited announced the successful passing of two special resolutions through postal ballot: approval of an Employee Stock Option Scheme granting at least 1% of issued capital to employees, and authorization to create a charge on company assets per Section 180(1)(a). Both resolutions achieved over 99% shareholder approval with remote e-voting completed by November 12, 2026.
Evonile Pharma Limited
Corporate Action
Evonile Pharma Limited has obtained shareholder approval through postal ballot for two key corporate actions: granting employee stock options equalling or exceeding 1% of issued capital under its Employee Stock Option Scheme 2026, and authorizing the creation of a charge on company assets in compliance with Section 180(1)(a) of the Companies Act.
The resolutions were passed via remote electronic voting by the company’s shareholders concluding on November 12, 2026, achieving an overall voting turnout of approximately 73.23% of outstanding shares.
For the Employee Stock Option Scheme 2026, all votes cast by the promoter and promoter group were in favor, representing 100% support of their 17,450,720 shares. Public institutions and non-institutional investors also largely supported the resolution, resulting in a 99.79% overall approval rate.
Similarly, the resolution to approve creation of charge on company assets was passed with 99.79% shareholder approval. This authorization enables the company to create security interests on its assets as required for financing or other strategic purposes.
The postal ballot notices were issued on October 8, 2026, with voting eligibility as per the shareholder record date on October 9, 2026. Full voting results and the scrutinizer's report were disclosed on November 13, 2026, in accordance with SEBI Listing Regulations.
Highlights
- Employee Stock Option Scheme 2026 approved to grant equal or more than 1% of issued capital to identified employees.
- Creation of charge on company assets authorized under Section 180(1)(a) as a special resolution.
- Resolutions passed with approximately 99.79% shareholder votes in favor.
- Remote e-voting concluded on November 12, 2026, with 73.23% of shares voting.
- Promoter and promoter group held 17,450,720 shares, voting 100% in favor.
- Public institution and non-institutional investors showed strong majority support.
Key Data Snapshot
What happened
- Evonile Pharma Limited completed a postal ballot approving two special resolutions by its shareholders as of November 12, 2026.
- The approved resolutions include the Employee Stock Option Scheme 2026 and the creation of charge on company assets.
Key details
- Employee Stock Option Scheme allows grant of stock options equal to or more than 1% of issued capital to identified employees.
- Charge creation authorized under Section 180(1)(a) of the Companies Act, permitting security interests on company assets.
- Resolutions passed by over 99.7% approval through remote electronic voting.
Regulatory and governance context
- Voting conducted in accordance with Companies Act, 2013 and SEBI Listing Regulations.
- Voting results and scrutinizer report published on company website for transparency.
- Postal ballot notice issued on October 8, 2026; shareholder eligibility fixed as of October 9, 2026.
Highlights
- Employee Stock Option Scheme 2026 approved to grant equal or more than 1% of issued capital to identified employees.
- Creation of charge on company assets authorized under Section 180(1)(a) as a special resolution.
- Resolutions passed with approximately 99.79% shareholder votes in favor.
- Remote e-voting concluded on November 12, 2026, with 73.23% of shares voting.
- Promoter and promoter group held 17,450,720 shares, voting 100% in favor.
- Public institution and non-institutional investors showed strong majority support.
Disclosures
- SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
- Companies Act, 2013 Sections 108 and 110
- Companies (Management and Administration) Rules, 2014 Rules 20 and 22
No promoter/promoter group interest in the resolutions
Source Information
More News on Corporate Action
View allLatest corporate announcements and market updates in Corporate Action.
String Metaverse Limited Grants 5 Crore Employee Stock Options at ₹8 Each Under 2023 Scheme
String Metaverse Limited has approved the grant of 5 crore employee stock options under its Employee Stock Option Scheme 2023, aimed at eligible employees of the company and its subsidiaries.
Read Full StoryUGRO Capital Allots INR 105 Crore Secured Non-Convertible Debentures at 9.75% Coupon
UGRO Capital Limited allotted 1,05,000 senior, secured non-convertible debentures totaling INR 105 crore on 19th November 2026 through private placement, carrying a coupon rate of 9.75% per annum payable monthly.
Read Full StoryTech Mahindra Allots 1,90,000 Equity Shares to ESOP Trust for Performance Share Plan 2025
Tech Mahindra Ltd has allotted 1,90,000 fully-paid equity shares of ₹5 each to its ESOP Trust to facilitate the Tech Mahindra Performance Share Plan 2025.
Read Full Story